LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 21.40 | 84.90 | 1346 | 1454 | 0.9253 | 0.9625 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 21.40 | 84.90 | 42 | 1454 | 0.0289 | -0.1578 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 21.40 | 84.90 | 1381 | 1454 | 0.9494 | 0.9748 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 23.10 | 84.90 | 92 | 1616 | 0.0569 | 0.0191 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 23.10 | 84.90 | 1447 | 1616 | 0.8953 | 0.9486 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 23.10 | 84.90 | 60 | 1616 | 0.0371 | -0.0784 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 23.10 | 84.90 | 1480 | 1616 | 0.9157 | 0.9590 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.81 | 84.90 | 106 | 1769 | 0.0599 | 0.0520 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.81 | 84.90 | 1608 | 1769 | 0.9087 | 0.9568 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.81 | 84.90 | 78 | 1769 | 0.0441 | -0.0192 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.81 | 84.90 | 1593 | 1769 | 0.9003 | 0.9526 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.51 | 84.90 | 130 | 1923 | 0.0676 | 0.0993 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.51 | 84.90 | 1711 | 1923 | 0.8897 | 0.9487 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.51 | 84.90 | 97 | 1923 | 0.0504 | 0.0300 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.51 | 84.90 | 1618 | 1923 | 0.8413 | 0.9247 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.21 | 84.90 | 153 | 2091 | 0.0732 | 0.1359 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.21 | 84.90 | 1747 | 2091 | 0.8353 | 0.9236 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.21 | 84.90 | 100 | 2091 | 0.0478 | 0.0361 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.21 | 84.90 | 1703 | 2091 | 0.8142 | 0.9130 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.92 | 84.90 | 170 | 2237 | 0.0760 | 0.1585 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.92 | 84.90 | 1881 | 2237 | 0.8406 | 0.9278 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.92 | 84.90 | 135 | 2237 | 0.0603 | 0.1033 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.92 | 84.90 | 1877 | 2237 | 0.8388 | 0.9269 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 31.62 | 84.90 | 182 | 2449 | 0.0743 | 0.1702 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 31.62 | 84.90 | 2085 | 2449 | 0.8511 | 0.9346 | MN20160318_Q02 | C19 |